The Weekly Scale: June 14th, 2021

This week at MarketScale, we dropped in on our newest series, explored how consumer behavior has changed, and filmed the pilot episode of The Next Great American Food Franchise. That’s making me hungry.

Break out the iced coffee, because its the start of summer — and it’s time to scale up.

Did you catch the release of our newest series, The Product Drop?

MarketScale is bringing something long overdue to the B2B marketplace — a live selling show on your own channel that will unite your products with potential B2B buyers. Don’t miss new episodes every Wednesday!

As COVID-19 restrictions ease, will merchants have to step up to entice in-store shoppers back with a more customer-centric experience?

This week on Next Level Commerce by FreedomPay, Visa and Sephora joined a discussion on how consumer behavior has changed post-COVID, how to solve for it, and new technology and innovations that are changing the payments landscape.

What does it take to be recognized in the ASU+GSV Elite 200?

On The Age of Digital Learning, host Kevin Hogan will be sitting down with the movers and shakers on the list as we lead up to the annual ASU+GSV Summit. Hogan will be talking the future of EdTech with some of the biggest names in technology: Deborah Quazzo, Sal Khan and a couple soon-to-be-mentioned A-List celebrities. Who do you want to see on the guest list?

Oracle is best known for its comprehensive and fully integrated stack of cloud applications and platform services, but might soon also be known for their cutting-edge Industries Innovation Lab.

This week on Track.Map.Measure, host Shaun MacIntosh sat down with Vice President Burcin Kaplanoglu to discuss how he realized that construction management in this day and age is all about one thing – harnessing the data.

The MarketScale Energy Roundtable is back and, this time, we are exploring the opportunities and challenges currently presented in our energy.

The panel will include:

Bill Lantz, JGL

Craig Kaiser, LandGate

Richa Yadav, Buro Happold

Nicole Bulgarino, Ameresco

Make sure to follow along for future roundtables. On Monday, June 14th, we will be diving into how the role of QSR franchises changes in mixed-use venues.

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More